D.H. Lee

First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆

Jiaxin Niu, Corinne Maurice‐Dror, D.H. Lee et al. · Annals of Oncology · 2021 · 287 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Placement of Covered Stents for Carotid Blowout in Patients with Head and Neck Cancer: Follow-up Results after Rescue Treatments

Hae Wook Pyun, D.H. Lee, Hyeon Mi Yoo et al. · American Journal of Neuroradiology · 2007 · 68 citations · Full text

Medicine, Oncology, Surgery +14

Belotecan, new camptothecin analogue, is active in patients with small-cell lung cancer: results of a multicenter early phase II study

D.H. Lee, S.-W. Kim, Cheolwon Suh et al. · Annals of Oncology · 2007 · 60 citations · Full text

Medicine, Oncology, Pharmacology +11

Effect of active smoking on asthma symptoms, pulmonary function, and BHR in adolescents

Sun Mi Yoo, H‐B. Kim, S‐Y. Lee et al. · Pediatric Pulmonology · 2009 · 46 citations

Public Health, Pediatrics, Adolescent Health +11

1400P Vibostolimab, an anti-TIGIT antibody, as monotherapy and in combination with pembrolizumab in anti-PD-1/PD-L1-refractory NSCLC

M-J. Ahn, Jiaxin Niu, Dongwook Kim et al. · Annals of Oncology · 2020 · 29 citations

Pharmacy, Oncology, Pharmacotherapy +14